Aida Aydemir

1.1k total citations · 1 hit paper
26 papers, 756 citations indexed

About

Aida Aydemir is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Aida Aydemir has authored 26 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 8 papers in Public Health, Environmental and Occupational Health and 6 papers in Surgery. Recurrent topics in Aida Aydemir's work include Osteoarthritis Treatment and Mechanisms (7 papers), Knee injuries and reconstruction techniques (5 papers) and Multiple Sclerosis Research Studies (5 papers). Aida Aydemir is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (7 papers), Knee injuries and reconstruction techniques (5 papers) and Multiple Sclerosis Research Studies (5 papers). Aida Aydemir collaborates with scholars based in United States, Germany and United Kingdom. Aida Aydemir's co-authors include F. Eckstein, Ali Guermazi, Marc C. Hochberg, Stephen Wax, Hans Guehring, J.R. Andersen, Asger Reinstrup Bihlet, I. Byrjalsen, Patricia Fleuranceau-Morel and S. Maschek and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Aida Aydemir

25 papers receiving 751 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis

2019 242 citations Marc C. Hochberg, Ali Guermazi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aida Aydemir United States	12	466	169	146	122	81	26	756
Fabienne Coury France	16	440 0.9×	137 0.8×	62 0.4×	306 2.5×	32 0.4×	56	998
İsmail Şimşek Türkiye	16	340 0.7×	132 0.8×	102 0.7×	195 1.6×	20 0.2×	54	697
Kai-Yuan Cheng China	11	279 0.6×	109 0.6×	41 0.3×	99 0.8×	11 0.1×	25	547
Masao Yukioka Japan	12	240 0.5×	94 0.6×	56 0.4×	123 1.0×	17 0.2×	44	586
Brent E. Appleton United States	8	362 0.8×	100 0.6×	196 1.3×	154 1.3×	11 0.1×	8	706
Michiyuki Hakozaki Japan	14	176 0.4×	145 0.9×	72 0.5×	97 0.8×	7 0.1×	68	646
Yeong Wook Song South Korea	19	319 0.7×	138 0.8×	29 0.2×	201 1.6×	39 0.5×	44	921
Sarah Onuora United States	10	189 0.4×	57 0.3×	53 0.4×	164 1.3×	19 0.2×	199	547
Manuel Pombo‐Suárez Spain	14	482 1.0×	151 0.9×	168 1.2×	226 1.9×	5 0.1×	28	809
Luana Andreea Macovei Romania	10	185 0.4×	61 0.4×	27 0.2×	58 0.5×	21 0.3×	51	395

Countries citing papers authored by Aida Aydemir

Since Specialization

Citations

This map shows the geographic impact of Aida Aydemir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aida Aydemir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aida Aydemir more than expected).

Fields of papers citing papers by Aida Aydemir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aida Aydemir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aida Aydemir. The network helps show where Aida Aydemir may publish in the future.

Co-authorship network of co-authors of Aida Aydemir

This figure shows the co-authorship network connecting the top 25 collaborators of Aida Aydemir. A scholar is included among the top collaborators of Aida Aydemir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aida Aydemir. Aida Aydemir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giovannoni, Gavin, Alexey Boyко, Jorge Correale, et al.. (2023). Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study. Multiple Sclerosis Journal. 29(6). 719–730. 23 indexed citations

Giovannoni, Gavin, Alexey Boyко, Jorge Correale, et al.. (2023). A Plain Language Summary on Assessing the Long-Term Effectiveness of Cladribine Tablets in People Living with Relapsing Multiple Sclerosis: The CLASSIC-MS Study. Neurodegenerative Disease Management. 13(5). 261–268. 1 indexed citations

Goteti, Kosalaram, Jonathan French, Ying Li, et al.. (2022). Disease trajectory of SLE clinical endpoints and covariates affecting disease severity and probability of response: Analysis of pooled patient‐level placebo (Standard‐of‐Care) data to enable model‐informed drug development. CPT Pharmacometrics & Systems Pharmacology. 12(2). 180–195. 7 indexed citations

Barratt, Jonathan, James A. Tumlin, Yusuke Suzuki, et al.. (2022). Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria. Kidney International Reports. 7(8). 1831–1841. 67 indexed citations

Butzkueven, Helmut, Nicholas Moore, Aida Aydemir, et al.. (2022). The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets. Current Medical Research and Opinion. 38(7). 1167–1176. 4 indexed citations

Wallace, Daniel J., David Isenberg, Eric F. Morand, et al.. (2021). Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus. Lara D. Veeken. 60(11). 5379–5389. 21 indexed citations

Kwoh, C. Kent, Hans Guehring, Aida Aydemir, et al.. (2020). Predicting knee replacement in participants eligible for disease-modifying osteoarthritis drug treatment with structural endpoints. Osteoarthritis and Cartilage. 28(6). 782–791. 14 indexed citations

Roemer, Frank W., Aida Aydemir, Stephen Wax, et al.. (2020). Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over 2 years. Osteoarthritis and Cartilage. 28(9). 1229–1234. 19 indexed citations

Barratt, Jonathan, James A. Tumlin, Yusuke Suzuki, et al.. (2020). MO039THE 24-WEEK INTERIM ANALYSIS RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF ATACICEPT IN PATIENTS WITH IGA NEPHROPATHY AND PERSISTENT PROTEINURIA. Nephrology Dialysis Transplantation. 35(Supplement_3). 11 indexed citations

10.

Rochester, Lynn, Claudia Mazzà, Arne Mueller, et al.. (2020). A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach. SHILAP Revista de lepidopterología. 4(Suppl. 1). 13–27. 71 indexed citations

11.

Eckstein, F., et al.. (2020). Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial. Annals of the Rheumatic Diseases. 79(4). 525–528. 59 indexed citations

12.

Barratt, Jonathan, James A. Tumlin, Yusuke Suzuki, et al.. (2020). 24-Week Interim Analysis of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Atacicept in Patients with IgA Nephropathy and Persistent Proteinuria. Journal of the American Society of Nephrology. 31(10S). 54–54. 2 indexed citations

13.

Eckstein, F., Stephen Wax, Aida Aydemir, et al.. (2018). Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of femorotibial location: a post-hoc analysis of a randomized, placebo-controlled phase ii clinical trial. Osteoarthritis and Cartilage. 26. S294–S294. 3 indexed citations

14.

Hochberg, Marc C., Ali Guermazi, Hans Guehring, et al.. (2018). Efficacy and safety of intra-articular Sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomized, placebo-controlled, phase II study. Osteoarthritis and Cartilage. 26. S26–S27. 5 indexed citations

15.

Hochberg, Marc C., Ali Guermazi, Hans Guehring, et al.. (2018). OP0059 Efficacy and safety of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomised, placebo-controlled, phase ii study. Annals of the Rheumatic Diseases. 77. 80–81. 10 indexed citations

16.

Roemer, Frank W., Aida Aydemir, Stephen Wax, et al.. (2018). FRI0538 Structural effects of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: a post-hoc analysis of cartilage and non-cartilaginous tissue alterations of the 2-year data from a 5-year randomised, placebo-controlled, phase ii study. Annals of the Rheumatic Diseases. 77. 795–795. 3 indexed citations

17.

Roemer, Frank W., Aida Aydemir, Stefan Lohmander, et al.. (2016). Structural effects of sprifermin in knee osteoarthritis: a post-hoc analysis on cartilage and non-cartilaginous tissue alterations in a randomized controlled trial. BMC Musculoskeletal Disorders. 17(1). 267–267. 42 indexed citations

18.

Eckstein, F., W. Wirth, Ali Guermazi, S. Maschek, & Aida Aydemir. (2015). Brief Report: Intraarticular Sprifermin Not Only Increases Cartilage Thickness, but Also Reduces Cartilage Loss: Location‐Independent Post Hoc Analysis Using Magnetic Resonance Imaging. Arthritis & Rheumatology. 67(11). 2916–2922. 61 indexed citations

19.

Castaño, Paula M., Aida Aydemir, Carole Sampson-Landers, & R. Lynen. (2013). The folate status of reproductive-aged women in a randomised trial of a folate-fortified oral contraceptive: dietary and blood assessments. Public Health Nutrition. 17(6). 1375–1383. 6 indexed citations

20.

Parker, Monica M., Andrew Reilly, Harold W. Horowitz, et al.. (2007). Prevalence of Drug-Resistant and Nonsubtype B HIV Strains in Antiretroviral-Naïve, HIV-Infected Individuals in New York State. AIDS Patient Care and STDs. 21(9). 644–652. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact